Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
Duan Z. Targeted DNase Hi-C. Methods Mol Biol. 2021;2157:65-83.
Long Y, Cech TR. Targeted mutagenesis in human iPSCs using CRISPR genome-editing tools. Methods. 2021.
Brown MA, Dotson GA, Ronquist S, Emons G, Rajapakse I, Ried T. TCF7L2 silencing results in altered gene expression patterns accompanied by local genomic reorganization. Neoplasia. 2021;23(2):257-269.
Mouti MAbdel, Pauklin S. TGFB1/INHBA homodimer/Nodal-SMAD2/3 Signalling Network: A Pivotal Molecular Target in PDAC Treatment. Mol Ther. 2021.
Gore A, Kadar T, Dachir S, Horwitz V. Therapeutic measures for sulfur mustard-induced ocular injury. Toxicol Lett. 2021.
Renaudin X, Rosselli F. Tipping the Scale: MYC Gains Weight in Fanconi Anemia Bone Marrow Failure Progression. Cell Stem Cell. 2021;28(1):8-9.
Mariniello K, Guasti L. Towards novel treatments for adrenal diseases: cell- and gene therapy-based approaches. Mol Cell Endocrinol. 2021:111160.
Li J, Qi D, Hsieh T-C, Huang JH, Wu JM, Wu E. Trailblazing perspectives on targeting breast cancer stem cells. Pharmacol Ther. 2021:107800.
Lin K-H, Chiang J-C, Chen W-M, Ho Y-H, Yao C-L, Lee H. Transcriptional regulation of lysophosphatidic acid receptors 2 and 3 regulates myeloid commitment of hematopoietic stem cells. Am J Physiol Cell Physiol. 2021.
Peshdary V, Hobbs CA, Maynor T, Shepard K, Gagné R, Williams A, Kuo B, Chepelev N, Recio L, Yauk C, et al. Transcriptomics and relative potency assessments using bench mark dose of bisphenol a, bisphenol S, bisphenol F, and 3,3',5,5'-Tetrabromobisphenol a in H9 human embryonic stem cells. Toxicol In Vitro. 2021:105097.
Weberling A, Zernicka-Goetz M. Trophectoderm mechanics direct epiblast shape upon embryo implantation. Cell Rep. 2021;34(3):108655.
Lammert A, Affolter A, Gvaramia D, Heid J, Jungbauer F, Scherl C, Tenschert E, Rotter N, Willett N, Kern J. [The tumor stem cell niche of head and neck - point of intersection with therapeutic potential?]. Laryngorhinootologie. 2021;100(1):23-29.
Wang W, Wang Q, Huang D-B, Sun Q-K, Wu S-S, Zhao Y-J, Jia W, Hu D-S, He Y-F. Tumor-associated mesenchymal stem cells promote hepatocellular carcinoma metastasis via a DNM3OS/KDM6B/TIAM1 axis. Cancer Lett. 2021.
Panchal N, Ghosh S, Booth C. T cell gene therapy to treat immunodeficiency. Br J Haematol. 2020.
Menacho C, Prigione A. Tackling mitochondrial diversity in brain function: from animal models to human brain organoids. Int J Biochem Cell Biol. 2020:105760.
Trifilio S, Rubin H, Monacelli A, Mehta J. Tacrolimus dose modification in patients receiving concomitant isavuconazole after hematopoietic stem cell transplantation. J Oncol Pharm Pract. 2020:1078155220940416.
Salles G, Duell J, Barca EGonzález, Tournilhac O, Jurczak W, Liberati AMarina, Nagy Z, Obr A, Gaidano G, André M, et al. Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study. Lancet Oncol. 2020.
Zhang C, Xu Z, Yang S, Sun G, Jia L, Zheng Z, Gu Q, Tao W, Cheng T, Li C, et al. tagHi-C Reveals 3D Chromatin Architecture Dynamics during Mouse Hematopoiesis. Cell Rep. 2020;32(13):108206.
Samadian H, Farzamfar S, Vaez A, Ehterami A, Bit A, Alam M, Goodarzi A, Darya G, Salehi M. A tailored polylactic acid/polycaprolactone biodegradable and bioactive 3D porous scaffold containing gelatin nanofibers and Taurine for bone regeneration. Sci Rep. 2020;10(1):13366.
Fan C, Shah Z, Ullah H, Philonenko ES, Zhang B, Tan Y, Wang C, Zhang J, Samokhvalov IM. TALEN-mediated biallelic inactivation of MYB in human embryonic stem cell lines WAe001-A-45 and WAe001-A-46. Stem Cell Res. 2020;46:101854.
Yang N, Chen H, Gao Y, Zhang S, Lin Q, Ji X, Li N, Xu W, Liu Y, Jin S. Tanshinone IIA exerts therapeutic effects by acting on endogenous stem cells in rats with liver cirrhosis. Biomed Pharmacother. 2020;132:110815.
Chen Y, Wang M-H, Zhu J-Y, Xie C-F, Li X-T, Wu J-S, Geng S-S, Han H-Y, Zhong C-Y. TAp63α targeting of Lgr5 mediates colorectal cancer stem cell properties and sulforaphane inhibition. Oncogenesis. 2020;9(10):89.
Turkina A, Wang J, Mathews V, Saydam G, Jung CWon, Hashmi HHassan Al, Yassin M, Le Clanche S, Miljkovic D, Slader C, et al. TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries. Br J Haematol. 2020.
Reinecke JBrandon, Roberts RDavid. Targetable Intercellular Signaling Pathways Facilitate Lung Colonization in Osteosarcoma. Adv Exp Med Biol. 2020;1258:111-123.
Felber M, Steward CG, Kentouche K, Fasth A, Wynn RF, Zeilhofer U, Haunerdinger V, Volkmer B, Prader S, Gruhn B, et al. Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis. Blood Adv. 2020;4(9):1998-2010.